Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 6,992 shares, a growth of 448.0% from the January 15th total of 1,276 shares. Based on an average trading volume of 22,566 shares, the days-to-cover ratio is presently 0.3 days. Based on an average trading volume of 22,566 shares, the days-to-cover ratio is presently 0.3 days.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on CZMWY shares. Sanford C. Bernstein downgraded shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. The Goldman Sachs Group downgraded shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 20th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Carl Zeiss Meditec presently has an average rating of “Hold”.
Read Our Latest Report on CZMWY
Carl Zeiss Meditec Stock Down 6.7%
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
